Skip to main content

About your Search

20120928
20121006
SHOW
STATION
KNTV (NBC) 2
LANGUAGE
Search Results 0 to 14 of about 15 (some duplicates have been removed)
CNBC
Sep 29, 2012 4:00am EDT
57-year-old man while waiting for the browns to take field for an hour and a half i'm going over this nike quarter. line by line. geez north america so strong 23. china so weak six. finally i realize, holy cow, nike's charging too much for its sneaks. that's all you need to know. we've been scaling back for the charitable trust. i think the stock goes higher i'm a seller. let's go to joe in texas, please, joe. >> caller: good day to you, mr. cramer. a question about the strength of the telecommunication industry. juniper. morgan stanley rate earnings estimate on cisco, should i be adding to my positions in juniper? >> i think juniper is a casually if not collateral damage of what could be a very good quarter coming with cisco. why i do say that? both morgan stanley and goldman said cisco's having a very strong quarter. it's coming out of someone's high. and i think it could be the giants. oh, i'm sorry. i mean juniper. goodbye, september. hello, october! it's all about the big picture. we have some optimism but we got to watch the big picture numbers. and this, the big day better be g
CNBC
Oct 2, 2012 11:00pm EDT
going to be, they are based on nothing. that is total thumb sucking. they ought to go bet on the browns. whatever, anyway, use the calendar to remind you when your anniversary is. not for investing. anyway, wow, try looking at the fundamentals, not your desk calendar. stay with cramer. >> coming up, cash crop? the midwest biggest drought in decades sent shares of mosaic up to 52 week highs. after failed earnings should you be harvesting your gains or doubling down? cramer talks exclusively to the ceo next. >> and later, retail rumble. wall street is at war over a big box giant, and when the analysts disagree it is your time to make "mad money." cramer is giving you a price check on costco. plus, seller's market? real estate stocks have been soaring. tonight cramer turns to the technicals to see if they are built to go higher or if their foundation is no longer stable. all coming up on "mad money." >>> we practice buying homework not buying whole. consider the agricultural space. people in developing countries are eating diets with more and more meat which requires more grain. that is a
CNBC
Oct 5, 2012 6:00pm EDT
the browns this weekend. all right. let's answer some of your tweets. over to my mark. this is a mark. try to give you tv instruction, kind of like the hashtag thing. first tweet from@l. barto 777. what is your position for guess? coming in with a high end line in november. coors, coackors, coach did well. >> i have stumbled on guess many times and do not like it. it's an aspirational brand that people have aspired to, and then kind of stopped aspiring to. next tweet from @kylenew york man. he tweeted. a web bush an his raised price tact on buffalo wild wings. a little late? yes, late, but this is better late than never. why do i say that? i say that because i think buffalo wild wings has been suffering from high-cost wings. wing prices go down, that stock will see $100. "mad money" back after the break. >>> not everything is political, for heaven's sake. we had the addition of 114 sn,0 jobs, hourly earnings higher than expected. nice revisions up from previous months, showing in particular that the report from august had understated the amount of job creation going on. i'm putti
NBC
Oct 4, 2012 3:00am PDT
to have a purple line well above a brown line, meaning you have a line that actually shows positive versus a placebo? >> yeah, so the six-minute walk test is the primary outcome measure that is studied to understand the progression of duchenne muscular dystrophy this is a disease which basically progresses until these boys, it mainly affects boys end up in a wheelchair. usually in their preteen or early teen years. and so we measure their progress or their progression of the disease by this measure, six-minute walk. we selected a population that we would have expected would have declined over 48 weeks. in fact, the placebo delayed treatment cohort that did decline through 36 weeks was something we expected. and that was a typical sign of this progressive disease. the fact that we showed a stabilization through 36 weeks excited the prospect of this drug. it excited the researchers and clinicians and the advocacy organizations in duchenne. now we've gone a step further. not only did we show stability through 48 weeks but we showed an improvement, as you mentioned. i'll also say the pl
Search Results 0 to 14 of about 15 (some duplicates have been removed)